FATAL TOXIC EPIDERMAL NECROLYSIS RELATED TO LAMOTRIGINE ADMINISTRATION

Citation
Rl. Page et al., FATAL TOXIC EPIDERMAL NECROLYSIS RELATED TO LAMOTRIGINE ADMINISTRATION, Pharmacotherapy, 18(2), 1998, pp. 392-398
Citations number
33
Categorie Soggetti
Pharmacology & Pharmacy
Journal title
ISSN journal
02770008
Volume
18
Issue
2
Year of publication
1998
Pages
392 - 398
Database
ISI
SICI code
0277-0008(1998)18:2<392:FTENRT>2.0.ZU;2-P
Abstract
Toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) ar e severe life-threatening dermatologic conditions. To date, eight case s of TEN and one of SJS related to lamotrigine administration have bee n reported in the literature. Most patients were also taking concomita nt valproic acid. It was hypothesized that valproic acid may interfere with glucuronidation of lamotrigine, leading to increased serum lamot rigine levels, or perhaps alter the drug's metabolism, resulting in ac cumulation of a toxic intermediate metabolite. Ultimately, this may po ssibly predispose a patient to increased dermatologic reactions, inclu ding TEN. A 54-year-old man developed TEN 4 weeks after beginning lamo trigine for complex partial seizures related to a glioblastoma multifo rme brain tumor. The patient had also been taking concomitant allopuri nol and captopril for more than 4 years with no complications, and val proic acid 3 months before the cutaneous event. Despite aggressive int ensive care management, the patient died 17 days from the onset of sym ptoms due to multiple organ failure. Administration of lamotrigine, es pecially in combination with valproic acid, may lead to the developmen t of TEN.